Research Article
Modeling a Telemedicine Screening Program for Diabetic Retinopathy in Iran and Implementing a Pilot Project in Tehran Suburb
Table 1
Demographic characteristics and medical data of the screened subjects.
| | Parameter | Level | Statistic | Value |
| | Age (years) | | Mean ± SD | 53 ± 14 | | | Median (range) | 56 (12–86) | | ≤25 | N (%) | 37 (6.1) | | 26–45 | N (%) | 110 (18.2) | | 46–65 | N (%) | 366 (60.6) | | >66 | N (%) | 91 (15.1) |
| | Sex | Female | N (%) | 415 (68.7) | | Male | N (%) | 189 (31.3) |
| | Type of diabetes | Type 1 | N (%) | 49 (8.4) | | Type 2 | N (%) | 531 (91.6) |
| | Duration of diabetes (years) | | Mean ± SD | 9 ± 7 | | | Median (range) | 8 (1–36) | | <10 | N (%) | 397 (65.7) | | 10–20 | N (%) | 165 (27.3) | | >20 | N (%) | 42 (7) |
| | Hemoglobin A1C | | Mean ± SD | 7.82 ± 1.6 | | | Median (range) | 7.6 (4.8–15) | | ≤7 | N (%) | 212 (35.1) | | 7–7/9 | N (%) | 116 (19.2) | | 8–9 | N (%) | 164 (27.2) | | >9 | N (%) | 112 (18.5) |
| | Current treatment | No treatment (improving life style) | N (%) | 7 (1.2) | | Oral medication | N (%) | 268 (44.4) | | Insulin | N (%) | 120 (19.9) | | Combination therapy | N (%) | 209 (34.6) |
|
|
N = number; SD = standard deviation. Combination therapy = oral and insulin therapies.
|
